Telesis Bio, Inc. (TBIO)
OTCMKTS · Delayed Price · Currency is USD
0.0220
+0.0010 (4.76%)
At close: Dec 5, 2025
Telesis Bio Revenue
Telesis Bio had revenue of $1.57M in the quarter ending September 30, 2024, a decrease of -61.79%. This brings the company's revenue in the last twelve months to $17.03M, down -32.54% year-over-year. In the year 2023, Telesis Bio had annual revenue of $27.51M with 0.27% growth.
Revenue (ttm)
17.03M
Revenue Growth
-32.54%
P/S Ratio
0.00
Revenue / Employee
436.77K
Employees
147
Market Cap
39.64K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 27.51M | 74.00K | 0.27% |
| Dec 31, 2022 | 27.44M | 16.39M | 148.44% |
| Dec 31, 2021 | 11.04M | 4.47M | 67.93% |
| Dec 31, 2020 | 6.58M | 810.00K | 14.05% |
| Dec 31, 2019 | 5.77M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Glass House Brands | 196.17M |
| Global Cord Blood | 196.10M |
| Elite Pharmaceuticals | 122.89M |
| Zomedica | 29.45M |
| Silence Therapeutics | 25.83M |
| Northwest Biotherapeutics | 937.00K |
Telesis Bio News
- 9 months ago - Telesis Bio secures up to $21M to accelerate adoption of Gibson SOLA - Seeking Alpha
- 1 year ago - Dow Surges Over 250 Points; Accenture Earnings Top Views - Benzinga
- 1 year ago - What's Going On With Telesis Bio Shares Thursday? - Benzinga
- 1 year ago - Crude Oil Down Over 2%; US Initial Jobless Claims Fall - Benzinga
- 1 year ago - Telesis Bio partners with Danaher company Beckman Coulter - Seeking Alpha
- 1 year ago - Why Telesis Bio Shares Are Trading Higher By Around 110%; Here Are 20 Stocks Moving Premarket - Benzinga
- 1 year ago - Telesis Bio Stock Is Soaring Wednesday: What's Going On? - Benzinga
- 1 year ago - Telesis Bio and Beckman Coulter Life Sciences Collaborate to Revolutionize DNA and mRNA Synthesis - GlobeNewsWire